Medicine without Meds: Revolutionising healthcare with digital solutions

10 Nov 2025

NUS Medicine and CHA University to harness artificial intelligence to tackle male infertility, uncovering new approaches to reverse fertility decline

Researchers from the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine) and CHA University in Korea have announced two major advances to extend reproductive longevity at the inaugural NUS-CHA Reproductive Medicine Symposium.

03 Nov 2025

Social interactions help to form lasting memories, NUS Medicine study finds

New findings underscore the importance of regular social interactions in life, shedding light on the strong link between loneliness and sustained social isolation to memory decline and conditions such as dementia, and why social and memory impairments often co-occur in psychiatric disorders.

29 Oct 2025

Silent bug carriers drive E. coli spread in households, NUS Medicine researchers find

Researchers from NUS Medicine have discovered that some people can carry large amounts of a multidrug-resistant strain of Escherichia coli sequence type 131 (E. coli ST131) in their gut for extended periods without showing any symptoms, and can unknowingly pass it on to their household members. The study, published in Nature Communications, is possibly the first in Asia to trace how this antibiotic-resistant bacterium spreads within the community.

27 Oct 2025

Increased risk of developing alcohol addiction linked to gene mutation

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore, have discovered how genetic variation in a single gene, chrna3, can alter alcohol sensitivity. These findings provide new insights into factors that may predispose individuals to alcohol use disorders and could inform personalised treatment plans.

22 Oct 2025

New drug combinations pave the way for personalised leukaemia therapies

Researchers from NUS Medicine have published a landmark review on BH3 mimetics—a new class of drugs that are reshaping the treatment landscape for acute myeloid leukaemia (AML), one of the most aggressive and treatment-resistant blood cancers.

17 Oct 2025

NUH and NUS launch new Molecular Imaging and Theranostics Centre to strengthen patient care and research

The National University Hospital (NUH) and the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have jointly launched the Molecular Imaging and Theranostics Centre, a novel integrated clinical, education, research and development facility that brings together advanced diagnostics, targeted therapy and pioneering research. This landmark development is set to transform the way diseases such as cancer are diagnosed, treated and studied, positioning Singapore at the forefront of molecular imaging in Asia.

14 Oct 2025

Safer, more effective vaccines with new mRNA vaccine technology

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua University has unveiled a new messenger ribonucleic acid (mRNA) vaccine technology that could make future vaccines safer, more effective, and less burdensome for patients.

13 Oct 2025

NUS Medicine launches new clinical trial centre to advance healthy longevity research

The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), today launched a new Clinical Trial Centre under its Academy for Healthy Longevity, a pioneering hub to advance clinical research and catalyse educational excellence in precision geromedicine. Spanning 350 square meters, the new Centre is poised to enhance research capabilities and accelerate the clinical translation of geroscience into real-world solutions. Precision geromedicine entail

06 Oct 2025

Map of bacterial gene interactions reveals potential drug targets

Despite rapid advances in reading the genetic code of living organisms, scientists still face a major challenge today - knowing a gene’s sequence does not automatically reveal what it does. Even in simple, well-studied bacteria like Escherichia coli (better known as E. coli), about one-quarter of the genes have no known function. Traditional approaches—turning off one gene at a time and studying the effects—are slow, laborious, and sometimes inconclusive due to gene redundancy.

02 Oct 2025

NUS Medicine researchers develop fat-like nanoparticles to treat fatty liver disease

Researchers from NUS Medicine have developed a novel RNA-based therapy that could transform treatment for metabolic dysfunction-associated steatohepatitis (MASH), previously known as Non-alcoholic fatty liver disease (NAFLD), which affects approximately 25% of people worldwide, and up to 40% of adults in Singapore.